Sanofi (SNY) Operating Leases (2019 - 2026)

Sanofi has disclosed Operating Leases across 8 years of filings, most recently posting $1.9 billion for Q2 2026.

• In Q2 2026, Operating Leases rose 12.99% year-over-year to $1.9 billion; the TTM figure through Jun 2026 stood at $1.9 billion (up 12.99% YoY), while the FY2025 annual figure was $1.7 billion, down 4.09% from the prior year.
• Operating Leases came in at $1.9 billion for Q2 2026 at Sanofi, up from $1.7 billion in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $2.1 billion in Q2 2022 to a low of $1.7 billion in Q4 2025.
• Average Operating Leases over 5 years is $1.9 billion, with a median of $1.9 billion recorded in 2023.
• The largest YoY upside for Operating Leases was 42.75% in 2022 against a maximum downside of 7.66% in 2022.
• Over 5 years, Operating Leases stood at $1.9 billion in 2022, then decreased by 2.79% to $1.9 billion in 2023, then fell by 6.91% to $1.8 billion in 2024, then retreated by 2.86% to $1.7 billion in 2025, then gained by 14.15% to $1.9 billion in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $1.9 billion in Q2 2026, $1.7 billion in Q4 2025, and $1.7 billion in Q2 2025.